Arne Risselada

853 total citations · 1 hit paper
29 papers, 573 citations indexed

About

Arne Risselada is a scholar working on Pharmacology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Arne Risselada has authored 29 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 9 papers in Psychiatry and Mental health and 8 papers in Pharmacology. Recurrent topics in Arne Risselada's work include Pharmacogenetics and Drug Metabolism (9 papers), Schizophrenia research and treatment (7 papers) and Treatment of Major Depression (4 papers). Arne Risselada is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Schizophrenia research and treatment (7 papers) and Treatment of Major Depression (4 papers). Arne Risselada collaborates with scholars based in Netherlands, United Kingdom and United States. Arne Risselada's co-authors include Iva Gunnarsson, Ronald van Vollenhoven, Lars Klareskog, Elisabet Welin Henriksson, T Jonsdottir, Hans Mulder, Eric N. van Roon, Bob Wilffert, Ron H. N. van Schaik and Richard Bruggeman and has published in prestigious journals such as The British Journal of Psychiatry, Annals of the Rheumatic Diseases and Psychopharmacology.

In The Last Decade

Arne Risselada

27 papers receiving 558 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics

2023 71 citations Marga Nijenhuis, Bianca Soree et al. European Journal of Human Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arne Risselada Netherlands	14	145	132	114	95	86	29	573
Pär Hallberg Sweden	18	52 0.4×	192 1.5×	60 0.5×	74 0.8×	137 1.6×	62	1.1k
Kentaro Oniki Japan	20	141 1.0×	80 0.6×	26 0.2×	45 0.5×	227 2.6×	87	1.1k
Carol Cronenberger United States	13	57 0.4×	39 0.3×	78 0.7×	173 1.8×	67 0.8×	28	540
Michael Heathman United States	12	54 0.4×	63 0.5×	26 0.2×	45 0.5×	170 2.0×	24	604
Kyoko Matsuguma Japan	12	54 0.4×	55 0.4×	27 0.2×	39 0.4×	115 1.3×	16	636
Christian Hengstenberg Germany	20	28 0.2×	46 0.3×	63 0.6×	94 1.0×	367 4.3×	37	1.1k
Mila Lovrić Croatia	16	165 1.1×	269 2.0×	32 0.3×	13 0.1×	162 1.9×	48	842
B Kattman United States	9	66 0.5×	126 1.0×	17 0.1×	30 0.3×	207 2.4×	25	676
María Talegón Spain	15	32 0.2×	126 1.0×	32 0.3×	164 1.7×	31 0.4×	17	408
Gina Mejía‐Abril Spain	15	105 0.7×	259 2.0×	16 0.1×	25 0.3×	123 1.4×	49	647

Countries citing papers authored by Arne Risselada

Since Specialization

Citations

This map shows the geographic impact of Arne Risselada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arne Risselada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arne Risselada more than expected).

Fields of papers citing papers by Arne Risselada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arne Risselada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arne Risselada. The network helps show where Arne Risselada may publish in the future.

Co-authorship network of co-authors of Arne Risselada

This figure shows the co-authorship network connecting the top 25 collaborators of Arne Risselada. A scholar is included among the top collaborators of Arne Risselada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arne Risselada. Arne Risselada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nijenhuis, Marga, et al.. (2026). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and CYP2C19 and tricyclic antidepressants. European Journal of Human Genetics. 34(3). 379–386.

Coenen, Marieke J. H., Marga Nijenhuis, Bianca Soree, et al.. (2025). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between TPMT/NUDT15 and thiopurines. European Journal of Human Genetics. 34(1). 152–160.

Manson, Lisanne E. N., Marga Nijenhuis, Bianca Soree, et al.. (2024). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs. European Journal of Human Genetics. 32(8). 903–911. 8 indexed citations

Nijenhuis, Marga, Bianca Soree, Nienke J. de Boer‐Veger, et al.. (2024). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP2C19 and non-SSRI/non-TCA antidepressants. European Journal of Human Genetics. 32(11). 1371–1377. 6 indexed citations

Nijenhuis, Marga, Bianca Soree, Nienke J. de Boer‐Veger, et al.. (2024). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between SLCO1B1 and statins and CYP2C9 and sulfonylureas. European Journal of Human Genetics. 33(4). 413–420. 2 indexed citations

Liemburg, Edith J., Fionneke M. Bos, Bennard Doornbos, et al.. (2023). Cardiovascular risk assessment methods yield unequal risk predictions: a large cross-sectional study in psychiatric secondary care outpatients. BMC Psychiatry. 23(1). 536–536. 4 indexed citations

Nijenhuis, Marga, Bianca Soree, Nienke J. de Boer‐Veger, et al.. (2023). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics. European Journal of Human Genetics. 32(3). 278–285. 71 indexed citations breakdown →

Jeuring, Hans W., et al.. (2022). The effectiveness of off-label dopamine stimulating agents in depressive disorder: A systematic review and meta-analysis. Psychiatry Research. 319. 115010–115010. 6 indexed citations

Nijenhuis, Marga, Bianca Soree, Nienke J. de Boer‐Veger, et al.. (2022). Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate. European Journal of Human Genetics. 32(2). 155–162. 20 indexed citations

10.

Nijenhuis, Marga, Bianca Soree, Nienke J. de Boer‐Veger, et al.. (2022). Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate. European Journal of Human Genetics. 31(12). 1364–1370. 16 indexed citations

11.

Brouwer, J., et al.. (2021). Applicability of somatic monitoring instructions in clinical practice guidelines on antipsychotic drug use. BMC Psychiatry. 21(1). 5 indexed citations

12.

Luykx, Jurjen J., et al.. (2020). Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic. The British Journal of Psychiatry. 217(3). 471–474. 25 indexed citations

13.

Schans, Jurjen van der, Eelko Hak, Maarten J. Postma, et al.. (2019). Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine. Journal of Clinical Psychopharmacology. 39(6). 583–590. 15 indexed citations

14.

Mulder, Hans, Arne Risselada, Frederik W. Wilmink, et al.. (2016). Medication Discrepancies at Outpatient Departments for Mood and Anxiety Disorders in the Netherlands. The Journal of Clinical Psychiatry. 77(11). 1511–1518. 7 indexed citations

15.

Buitenwerf, Edward, Arne Risselada, Eric N. van Roon, Nic J.G.M. Veeger, & Marc H. Hemmelder. (2015). Effect of nadroparin on anti-Xa activity during nocturnal hemodialysis. PubMed. 3. 276–279. 5 indexed citations

16.

Hak, Eelko, Maarten J. Postma, Marjolein Boshuisen, et al.. (2015). Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial). Trials. 16(1). 37–37. 13 indexed citations

17.

Vehof, Jelle, A.F.Y. Al Hadithy, Huibert Burger, et al.. (2011). Association between the ROBO1 gene and body mass index in patients using antipsychotics. Psychiatric Genetics. 21(4). 202–207. 7 indexed citations

18.

Risselada, Arne, et al.. (2010). Life-threatening complications of vitamin D intoxication due to over-the-counter supplements. Clinical Toxicology. 48(5). 460–462. 31 indexed citations

19.

Risselada, Arne, Jelle Vehof, Richard Bruggeman, et al.. (2010). Association Between the 1291-C/G Polymorphism in the Adrenergic α-2a Receptor and the Metabolic Syndrome. Journal of Clinical Psychopharmacology. 30(6). 667–671. 14 indexed citations

20.

Bemt, Patricia M. L. A. van den, et al.. (2002). The potential interaction between oral anticoagulants and acetaminophen in everyday practice.. Pharmacy World & Science. 24(5). 201–204. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact